Zhongchao Inc. Announces $5.0 Million Registered Direct Offering

Zhongchao Inc. (NASDAQ: ZCMD) has announced a definitive agreement to raise approximately $5 million through a registered direct offering of 4,545,455 Class A Ordinary Shares at a price of $1.10 per share. The transaction is expected to close on or about July 24, 2026, pending customary closing conditions. Univest Securities, LLC is acting as the sole placement agent for this offering, which is being conducted under the company's existing shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC).

Zhongchao Inc., an offshore holding company based in the Cayman Islands, operates primarily through its variable interest entity, Zhongchao Medical Technology (Shanghai) Limited, and its subsidiaries. The company focuses on providing internet technology solutions in the healthcare sector, particularly for oncology and other major diseases. Its platforms, including the "MDMOOC" for healthcare professional training and the Zhixun Internet Hospital for patient management, underscore its commitment to enhancing healthcare delivery through technology.

The strategic rationale behind this fundraising initiative appears to be aligned with Zhongchao's ongoing efforts to expand its service offerings and enhance its technological capabilities in the rapidly evolving healthcare landscape. With a growing emphasis on digital health solutions, the capital raised from this offering may be directed toward further developing its online healthcare platforms and expanding its reach within the Chinese healthcare market.

The broader healthcare sector is witnessing a significant shift towards digitalization, driven by increasing demand for telehealth services and online healthcare information. Companies like Zhongchao are well-positioned to capitalize on this trend, particularly as healthcare providers and patients alike seek more accessible and efficient solutions. The successful completion of this fundraising round will likely bolster Zhongchao's ability to innovate and compete in this dynamic environment.

As the market continues to evolve, the implications of this fundraising extend beyond Zhongchao itself. Investors are increasingly looking for opportunities within the digital health sector, which is expected to grow substantially in the coming years. The ability of Zhongchao to effectively utilize the proceeds from this offering could serve as a bellwether for similar companies seeking to navigate the challenges and opportunities presented by the ongoing transformation in healthcare delivery.